In patients with stroke or TIA and CYP2C19 loss-of-function alleles, ticagrelor vs. clopidogrel reduced 90-d stroke

被引:1
|
作者
Joundi, Raed A. [1 ]
机构
[1] McMaster Univ, Hamilton, ON, Canada
关键词
MINOR STROKE; ASPIRIN;
D O I
10.7326/J22-0008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:JC30 / JC30
页数:1
相关论文
共 36 条
  • [31] Efficacy and safety of CYP2C19 genotype in stroke or transient ischemic attack patients treated with clopidogrel monotherapy or clopidogrel plus aspirin Protocol for a systemic review and meta-analysis
    Yao, Jia-Chen
    Cui, Min
    Pan, Mang-Mang
    Gu, Zhi-Chun
    Li, Wen-Yan
    MEDICINE, 2018, 97 (24)
  • [32] Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial
    Xie, Xuewei
    Jing, Jing
    Wang, Anxin
    Xu, Qin
    Zhao, Xingquan
    Lin, Jinxi
    Chen, Pan
    Jiang, Yong
    Wang, Yilong
    Li, Hao
    Meng, Xia
    Wang, Yongjun
    STROKE AND VASCULAR NEUROLOGY, 2025,
  • [33] Body weight,CYP2C19, andP2Y12receptor polymorphisms relate to clopidogrel resistance in a cohort of Chinese ischemic stroke patients with aspirin intolerance
    Li, Zhiqiang
    Dong, Wanqing
    Yang, Daorong
    Sun, Linhai
    He, Xianjun
    Hu, Huanhuan
    Zhang, Jianping
    Wang, Chunyu
    Li, Yulin
    Zhao, Ming
    Kong, Yu
    Wang, Yan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (11) : 1517 - 1527
  • [34] Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation
    Tabata, Noriaki
    Hokimoto, Seiji
    Akasaka, Tomonori
    Arima, Yuichiro
    Sakamoto, Kenji
    Yamamoto, Eiichiro
    Tsujita, Kenichi
    Izumiya, Yasuhiro
    Yamamuro, Megumi
    Kojima, Sunao
    Kaikita, Koichi
    Kumagae, Naoki
    Morita, Kazunori
    Oniki, Kentaro
    Nakagawa, Kazuko
    Matsui, Kunihiko
    Ogawa, Hisao
    JOURNAL OF CARDIOLOGY, 2016, 67 (1-2) : 104 - 109
  • [35] A randomized controlled trial to assess the efficacy and safety of doubling dose clopidogrel versus ticagrelor for the treatment of acute coronary syndrome in patients with CYP2C19*2 homozygotes
    Xiong, Ran
    Liu, Wenxian
    Chen, Liying
    Kang, Tieduo
    Ning, Shangqiu
    Li, Jiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 13310 - 13316
  • [36] Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel
    Zabalza, Michel
    Subirana, Isaac
    Sala, Joan
    Lluis-Ganella, Carla
    Lucas, Gavin
    Tomas, Marta
    Masia, Rafel
    Marrugat, Jaume
    Brugada, Ramon
    Elosua, Roberto
    HEART, 2012, 98 (02) : 100 - 108